Masanori Shimomura

Masanori Shimomura

Auto-generated profile, based on publicly available information

Masanori Shimomura

Division of Thoracic Surgery, Department of Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2022 in Lung Cancer
Verified
Journal Article
Closed access
MSMasanori Shimomura
Masanori Shimomura
AMAya Miyagawa-Hayashino
Aya Miyagawa-Hayashino
IOIkoi Omatsu
Ikoi Omatsu
YAYumi Asai
Yumi Asai
SIShunta Ishihara
Shunta Ishihara
MIMasayoshi Inoue
Masayoshi Inoue

30 May 2022 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
SOSatoru Okada
Satoru Okada
MSMasanori Shimomura
Masanori Shimomura
SIShunta Ishihara
Shunta Ishihara
SISatoshi Ikebe
Satoshi Ikebe
TFTatsuo Furuya
Tatsuo Furuya
MIMasayoshi Inoue
Masayoshi Inoue
An increasing number of elderly patients with impaired immunity, malnutrition and comorbidities are considered surgical candidates. This study aimed to clarify the predictive factors and prognostic impact of postoperative pulmonary complications in elderly patients with lung cancer. This retrospective study included 188 patients (≥75 years) who underwent complete anatomical lung resection for non-small cell lung cancer between 2005 and 2019. Postoperative pulmonary complications graded ≥II in the Clavien-Dindo classification, occurring within 30-day post-surgery were evaluated. Multivariate logistic regression analyses and Cox proportional hazard models were used to analyse predictors and prognostic impact of complications. Video-assisted thoracoscopic surgery was performed in 154 patients (81.9%). The 90-day mortality rate was 0.5%. Postoperative pulmonary complications including air leak, pneumonia, sputum retention, atelectasis, bronchopleural fistula and empyema occurred in 29 patients (15.4%). A lower prognostic nutritional index (<45) and longer operative time were independent predictive factors of pulmonary complications, with 33.3% of patients experiencing both factors. Following a median follow-up of 48 months, the 5-year overall and relapse-free survival rates were significantly worse in patients with pulmonary complications than in those without them (54.4% vs 81.5% and 41.2% vs 74.9%). Pulmonary complications were significantly associated with worse overall and relapse-free survival [hazard ratio (95% confidence interval): 1.97 (1.01–3.66), P = 0.047 and 2.35 (1.28–4.12), P = 0.007, respectively] along with pathologic stage and carcinoembryonic antigen levels. Postoperative pulmonary complications are associated with a lower prognostic nutritional index and prolonged operative time; the complications are independent adverse prognostic factors in elderly patients.

13 December 2011 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
MSMasanori Shimomura
Masanori Shimomura
TYTakeshi Yaoi
Takeshi Yaoi
KIKyoko Itoh
Kyoko Itoh
DKDaishiro Kato
Daishiro Kato
KTKunihiko Terauchi
Kunihiko Terauchi
SFShinji Fushiki
Shinji Fushiki
In order to clarify the mechanisms of resistance to paclitaxel in lung cancer, three human lung cancer cell lines which exhibit different sensitivity to paclitaxel were investigated from the following viewpoints: overexpression of ATP-binding cassette, sub-family B, member 1 (ABCB1), mutations on paclitaxel binding site of β-tubulin genes, quantity of polymerized tubulin and the intracellular localization of paclitaxel. ABCB1 expression was evaluated by real-time RT-PCR. No correlations were noted between the ABCB1 expression in the sensitive and resistant cell lines at the mRNA level. No mutations on the paclitaxel binding site of the β-tubulin genes were detected in either the resistant or sensitive cells. Live cell images obtained by confocal laser microscopy revealed that the resistant cell line, RERF-LC-KJ, had more accumulation of Oregon Green® 488 conjugated paclitaxel in the lysosomal and extra-lysosomal compartments of cytoplasm than other cell lines. The results obtained in this study indicated that the changes in the subcellular localization could contribute to the production of paclitaxel resistance in lung cancer cell lines. Further studies should be conducted to elucidate the molecular mechanisms that differentiate the intracellular localization of paclitaxel.

21 April 2022 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
MSMasanori Shimomura
Masanori Shimomura
SIShunta Ishihara
Shunta Ishihara
SOSatoru Okada
Satoru Okada
MIMasayoshi Inoue
Masayoshi Inoue
Robot-assisted thymectomy through a subxiphoid scopic approach can provide a good surgical view, similar to that of median sternotomy. We originally used the subxiphoid port only for the robotic scope to avoid instrument collision with the assistant device. This approach, robotic subxiphoid-optical thymectomy, is advantageous for the safe and accurate dissection of the bilateral phrenic nerves and the left brachiocephalic vein, which are especially needed in extended thymectomy for patients with myasthenia gravis.

1 November 2020 in Lung Cancer
Verified
Journal Article
Closed access
NTNaoko Takeda-Miyata
Naoko Takeda-Miyata
EKEiichi Konishi
Eiichi Konishi
TTTadashi Tanaka
Tadashi Tanaka
MSMasanori Shimomura
Masanori Shimomura
HTHiroaki Tsunezuka
Hiroaki Tsunezuka
MIMasayoshi Inoue
Masayoshi Inoue

8 August 2019 in The Thoracic and Cardiovascular Surgeon
Verified
Journal Article
Closed access
PDF file
MSMasanori Shimomura
Masanori Shimomura
MIMasashi Iwasaki
Masashi Iwasaki
SIShunta Ishihara
Shunta Ishihara
MIMasayoshi Inoue
Masayoshi Inoue
Background We investigated the postoperative upstaging of stage I and II lung adenocarcinoma patients to identify useful predictors for accurate staging. Methods We retrospectively reviewed data from 80 consecutive patients undergoing lobectomy and mediastinal lymph node dissection for clinical stage I and II lung adenocarcinomas. We evaluated clinical variables, including the preoperative serum carcinoembryonic antigen (CEA), tumor diameter, consolidation-to-tumor ratio (CTR), maximum standardized uptake value (SUVmax) on FDG- PET, expression of epithelial growth factor receptor mutations, and pathological invasion to the pleura (pl), lymph duct (ly), and vein (v). Results Eleven patients (13.8%) showed postoperative upstaging. Three cases had pN1 migrating from cN0, four cases had pN2 from cN0, and four cases showed malignant pleural effusion. The CEA level and CTR were significantly higher in the upstaging group. The tumors in the upstaging group showed more frequent pathological invasion to the visceral pleura and vein. In patients with 3 cm or smaller consolidation, two-dimensional (2D)-CTR and volume-based CTR were independent predictors of upstaging. Conclusions Volume-based CTR could be a useful predictor for accurate clinical staging in stage I and II adenocarcinoma patients in addition to consolidation size, serum CEA level, and 2D-CTR. Both volume-based and 2D-CTRs might be especially useful in T1 diseases.